From Biotech to Big Pharma: Building a Modern Compute Environment that Thrives at Any Scale

About This Webinar
In an industry driven by the pursuit of progress, the ability for biopharma teams to fully harness innovation and technology to support discovery has long been a differentiator.

In this Q&A-based session presented by RCH Solutions, hear a well-known leader in the application of computing systems in bio-pharmas large and small, Clarence J. Wang, Ph.D., share lessons learned and best practices for the development of a Cloud-enabled, high-performing compute environment that supports the needs of both the business and IT, in organizations of all scale.



Meet The Speakers

Clarence Wang, Ph.D.
V.P. and Head of Data Sciences at Dyne Therapeutic

Currently serving as Head of Data Sciences at Dyne Therapeutics, Dr. Wang has led the application of computing systems in biopharma for over 25 years.  Known for his balanced perspective of innovative yet practical approaches to the development of data-driven, technology-based solutions for R&D challenges,  he has led scientists and technologists responsible for computational research and informatics supporting a wide range of activities from discovery through the product life cycle. Prior to Dyne, Dr. Wang served as Group Head, Science Computing, in the Translational Sciences group in Sanofi. He holds a B.S. from Harvey Mudd College and a Ph.D. in organic chemistry from Cornell University and was a 1984 Thomas J. Watson Fellow.

Michael Riener
President & CEO, RCH Solutions
Michael oversees the executive management of RCH, including the company’s overall strategic direction, and brings more than 25 years of experience to his role. His primary responsibilities are business development, sales and marketing. Michael has been an officer since 2006 and was instrumental in the evolution of the company’s business model. During this time, RCH has experienced significant market and revenue growth in Life Sciences and Healthcare industries.